{"id":"https://openalex.org/W2469609771","doi":"https://doi.org/10.1182/blood.v126.23.3910.3910","title":"Systematic Analysis of Cell-of-Origin, Sequencing and Genomic Imbalances Identifies a Distinct Subset of Rituximab Treated Diffuse Large B-Cell Lymphoma with an Inferior Survival","display_name":"Systematic Analysis of Cell-of-Origin, Sequencing and Genomic Imbalances Identifies a Distinct Subset of Rituximab Treated Diffuse Large B-Cell Lymphoma with an Inferior Survival","publication_year":2015,"publication_date":"2015-12-03","ids":{"openalex":"https://openalex.org/W2469609771","doi":"https://doi.org/10.1182/blood.v126.23.3910.3910","mag":"2469609771"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v126.23.3910.3910","doi":"https://doi.org/10.1182/blood.v126.23.3910.3910","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v126.23.3910.3910","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5107967182","display_name":"Rajan Dewar","orcid":"https://orcid.org/0000-0003-0937-0190","observed_orcids":["https://orcid.org/0000-0003-0937-0190"]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rajan Dewar","raw_affiliation_strings":["Department of Pathology, Harvard Medical School and Beth Israel Deaconess Medical Center, Boston, MA","Department of Pathology, University of Michigan, Ann Arbor, MI"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology, Harvard Medical School and Beth Israel Deaconess Medical Center, Boston, MA","institution_ids":["https://openalex.org/I1316535847","https://openalex.org/I136199984"]},{"raw_affiliation_string":"Department of Pathology, University of Michigan, Ann Arbor, MI","institution_ids":["https://openalex.org/I27837315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018872723","display_name":"Julia Friedman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210145812","display_name":"Cancer Genetics (United States)","ror":"https://ror.org/05feyya22","country_code":"US","type":"company","lineage":["https://openalex.org/I4210145812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Julia Friedman","raw_affiliation_strings":["Cancer Genetics, Inc., Rutherford, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Genetics, Inc., Rutherford, NJ","institution_ids":["https://openalex.org/I4210145812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040987010","display_name":"Daniel Xia","orcid":"https://orcid.org/0000-0003-3825-0577","observed_orcids":["https://orcid.org/0000-0003-3825-0577"]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel Xia","raw_affiliation_strings":["Department of Pathology, Harvard Medical School and Beth Israel Deaconess Medical Center, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology, Harvard Medical School and Beth Israel Deaconess Medical Center, Boston, MA","institution_ids":["https://openalex.org/I1316535847","https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049605498","display_name":"Timothy George Lens","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Timothy George Lens","raw_affiliation_strings":["Division of Hematology and Oncology, Harvard Medical School and Beth Israel Deaconess Medical Center, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Oncology, Harvard Medical School and Beth Israel Deaconess Medical Center, Boston, MA","institution_ids":["https://openalex.org/I1316535847","https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030209609","display_name":"Asha N. Guttapalli","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210145812","display_name":"Cancer Genetics (United States)","ror":"https://ror.org/05feyya22","country_code":"US","type":"company","lineage":["https://openalex.org/I4210145812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Asha Guttapalli","raw_affiliation_strings":["Cancer Genetics, Inc., Rutherford, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Genetics, Inc., Rutherford, NJ","institution_ids":["https://openalex.org/I4210145812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005365729","display_name":"Phillip D. Michaels","orcid":"https://orcid.org/0000-0003-3827-953X","observed_orcids":["https://orcid.org/0000-0003-3827-953X"]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Phillip Michaels","raw_affiliation_strings":["Department of Pathology, Harvard Medical School and Beth Israel Deaconess Medical Center, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology, Harvard Medical School and Beth Israel Deaconess Medical Center, Boston, MA","institution_ids":["https://openalex.org/I1316535847","https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005195883","display_name":"Venkata Jaganmohan Thodima","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210145812","display_name":"Cancer Genetics (United States)","ror":"https://ror.org/05feyya22","country_code":"US","type":"company","lineage":["https://openalex.org/I4210145812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Venkata Thodima","raw_affiliation_strings":["Cancer Genetics, Inc., Rutherford, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Genetics, Inc., Rutherford, NJ","institution_ids":["https://openalex.org/I4210145812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003078936","display_name":"Sitharthan Kamalakaran","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210145812","display_name":"Cancer Genetics (United States)","ror":"https://ror.org/05feyya22","country_code":"US","type":"company","lineage":["https://openalex.org/I4210145812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sitharthan Kamalakaran","raw_affiliation_strings":["Cancer Genetics, Inc., Rutherford, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Genetics, Inc., Rutherford, NJ","institution_ids":["https://openalex.org/I4210145812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052154203","display_name":"Jane Houldsworth","orcid":"https://orcid.org/0000-0002-6781-1700","observed_orcids":["https://orcid.org/0000-0002-6781-1700"]},"institutions":[{"id":"https://openalex.org/I4210145812","display_name":"Cancer Genetics (United States)","ror":"https://ror.org/05feyya22","country_code":"US","type":"company","lineage":["https://openalex.org/I4210145812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jane Houldsworth","raw_affiliation_strings":["Cancer Genetics, Inc., Rutherford, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Genetics, Inc., Rutherford, NJ","institution_ids":["https://openalex.org/I4210145812"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5028590331","display_name":"Robin Joyce","orcid":"https://orcid.org/0000-0002-7251-8082","observed_orcids":["https://orcid.org/0000-0002-7251-8082"]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robin Joyce","raw_affiliation_strings":["Division of Hematology and Oncology, Harvard Medical School and Beth Israel Deaconess Medical Center, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Oncology, Harvard Medical School and Beth Israel Deaconess Medical Center, Boston, MA","institution_ids":["https://openalex.org/I1316535847","https://openalex.org/I136199984"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.24876774,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"126","issue":"23","first_page":"3910","last_page":"3910"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12212","display_name":"CNS Lymphoma Diagnosis and Treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/diffuse-large-b-cell-lymphoma","display_name":"diffuse large B-cell lymphoma","score":0.9980000257492065},{"id":"https://openalex.org/keywords/rituximab","display_name":"rituximab","score":0.8980000019073486},{"id":"https://openalex.org/keywords/cell-of-origin","display_name":"cell of origin","score":0.9240000247955322},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.9369999766349792},{"id":"https://openalex.org/keywords/copy-number-variation","display_name":"copy number variation","score":0.7490000128746033},{"id":"https://openalex.org/keywords/genomic-imbalances","display_name":"genomic imbalances","score":0.8519999980926514},{"id":"https://openalex.org/keywords/single-gene-mutations","display_name":"single-gene mutations","score":0.6209999918937683},{"id":"https://openalex.org/keywords/r-chop","display_name":"R-CHOP","score":0.7039999961853027},{"id":"https://openalex.org/keywords/r-epoch","display_name":"R-EPOCH","score":0.9160000085830688},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.7310000061988831},{"id":"https://openalex.org/keywords/immunoglobulin-heavy-chain-gene-rearrangement","display_name":"immunoglobulin heavy chain gene rearrangement","score":0.37299999594688416},{"id":"https://openalex.org/keywords/myc-rearrangement","display_name":"MYC rearrangement","score":0.4959999918937683},{"id":"https://openalex.org/keywords/bcl2-rearrangement","display_name":"BCL2 rearrangement","score":0.546999990940094}],"concepts":[{"id":"https://openalex.org/C2778559949","wikidata":"https://www.wikidata.org/wiki/Q2626074","display_name":"Diffuse large B-cell lymphoma","level":3,"score":0.7597830295562744},{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.7454434633255005},{"id":"https://openalex.org/C124942203","wikidata":"https://www.wikidata.org/wiki/Q656638","display_name":"Comparative genomic hybridization","level":4,"score":0.6986843347549438},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4916072487831116},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.484519898891449},{"id":"https://openalex.org/C204232928","wikidata":"https://www.wikidata.org/wiki/Q899285","display_name":"Immunohistochemistry","level":2,"score":0.4731903076171875},{"id":"https://openalex.org/C120821319","wikidata":"https://www.wikidata.org/wiki/Q1501491","display_name":"Copy-number variation","level":4,"score":0.46629494428634644},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.43731749057769775},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.43072929978370667},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.39778855443000793},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.36137157678604126},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3319801688194275},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.14666405320167542},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.12712103128433228},{"id":"https://openalex.org/C141231307","wikidata":"https://www.wikidata.org/wiki/Q7020","display_name":"Genome","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v126.23.3910.3910","doi":"https://doi.org/10.1182/blood.v126.23.3910.3910","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v126.23.3910.3910","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2232969484","https://openalex.org/W3135063378","https://openalex.org/W2606757383","https://openalex.org/W2339158107","https://openalex.org/W2591080491","https://openalex.org/W2741305525","https://openalex.org/W1898697707","https://openalex.org/W3017091259","https://openalex.org/W2563223562","https://openalex.org/W3157181626"],"abstract_inverted_index":{"Abstract":[0],"Introduction:":[1],"Diffuse":[2],"Large":[3],"B-cell":[4],"Lymphoma":[5,321],"(DLBCL),":[6],"exhibits":[7],"a":[8,87,106,113,216,289,297],"wide":[9],"range":[10],"of":[11,26,35,49,68,92,98,108,115,207,212,239,249,342,348,405,428,433,467,515,535,550],"clinical":[12,413],"and":[13,129,166,168,190,294,318,337,359,385,412,440,540,545,563],"biological":[14],"heterogeneity.":[15],"While":[16],"initially":[17],"responsive":[18],"to":[19,46,61,103,140,205,222,340,580],"rituximab":[20,80,459,502,557],"based":[21,81,262,267,307,460],"therapy,":[22],"more":[23],"than":[24,149],"70%":[25],"patients":[27,77,109,157,407,429,456,504],"relapse":[28],"within":[29],"5":[30],"years.":[31],"Two":[32],"distinct":[33],"subtypes":[34],"DLBCLs":[36,536],"were":[37,174,183,193,261,328,351,363,470,484],"previously":[38,217],"identified":[39,543],"by":[40,71,119,124,133,366,474,490,586],"gene":[41,131,482],"expression":[42],"profiling,":[43],"that":[44,145],"correlated":[45],"the":[47,66,90,99,210,235,304,326,380,431,446,455,468,513,516],"cell":[48],"origin":[50],"(COO);":[51],"currently":[52],"an":[53,402,418],"immunohistochemistry":[54],"(IHC)":[55],"surrogate":[56],"(Hans":[57],"algorithm)":[58],"is":[59,73,86,102,139,415,423],"used":[60],"identify":[62,141],"this":[63,371],"COO.":[64],"However,":[65],"value":[67,527],"COO":[69,118,154,411,447,585],"identification":[70,91],"IHC":[72],"being":[74],"questioned":[75],"in":[76,155,313,331,424,454,501,552,558],"treated":[78,158,169,457,503,555],"with":[79,110,159,170,408,437,452,458,472,487,499,505,556],"regimen.":[82],"As":[83],"such":[84,152],"there":[85],"need":[88],"for":[89,220,234,303,325,353,509,522],"additional":[93,419,566],"prognostication":[94],"markers.":[95],"The":[96,137,258,361],"purpose":[97],"present":[100],"study":[101],"systematically":[104],"characterize":[105],"cohort":[107],"DLBCL":[111,156,232,553],"using":[112,288,379,395,537],"variety":[114],"methods":[116,151,542,582],"including":[117],"IHC,":[120],"copy":[121,241,269,546],"number":[122,242,270,547],"changes":[123],"array-based":[125],"comparative":[126],"genomic":[127,224,251,343],"hybridization,":[128],"single":[130],"mutations":[132,483,518],"next":[134],"generation":[135],"sequencing.":[136],"goal":[138],"prognostic":[142],"molecular":[143,541,572],"biomarkers":[144,548,573],"predict":[146,576],"survival":[147,181,391,453,473,489,500,551],"better":[148,510,575],"current":[150,581],"as":[153,584],"rituximab.":[160],"Methods:":[161],"Patients":[162],"diagnosed":[163],"between":[164],"2003":[165],"2011":[167],"R-CHOP/R-EPOCH":[171],"at":[172,430],"BIDMC":[173],"identified.":[175],"IPI/R-IPI,":[176],"ECOG":[177],"performance":[178],"status,":[179],"overall":[180],"data":[182,271,564],"collected":[184],"from":[185,226,245,272,565],"retrospective":[186],"chart":[187],"review.":[188],"Molecular":[189],"immunohistochemical":[191,539],"studies":[192],"performed":[194,287,352,394],"on":[195,263,268,296,308,401],"formalin-fixed":[196],"paraffin":[197],"embedded":[198],"tissue":[199],"(FFPE),":[200],"which":[201],"was":[202,286,306,377,393,435,448],"obtained":[203],"prior":[204],"initiation":[206],"therapy":[208],"(at":[209],"time":[211,432],"diagnosis).":[213],"aCGH:":[214],"Using":[215],"developed":[218],"assay":[219],"aCGH":[221],"detect":[223],"gain/loss":[225],"archival":[227],"FFPE,":[228],"we":[229],"characterized":[230],"each":[231],"sample":[233],"presence":[236,514],"or":[237,345,519],"absence":[238],"50":[240],"variations":[243],"(CNVs)":[244],"32":[246],"common":[247,256],"regions":[248],"overlapping":[250],"imbalances":[252],"comprising":[253],"36":[254],"minimal":[255],"regions.":[257],"calling":[259],"criteria":[260],"GISTIC":[264],"defined":[265],"peaks":[266],"three":[273,367,466],"publicly":[274],"available":[275],"datasets:":[276],"IS-172,":[277],"IS-51HR,":[278],"EMEXP-3463.":[279],"Gene":[280,301],"panels:":[281],"Next":[282],"Generation":[283],"Sequencing":[284],"(NGS)":[285],"targeted":[290],"hybrid":[291],"capture":[292],"panel":[293,305,327],"run":[295],"Miseq":[298],"(Illumina,":[299],"Inc.).":[300],"selection":[302],"frequently":[309],"mutated":[310],"genes":[311,329,338],"reported":[312],"DLBCL,":[314],"Follicular":[315],"lymphoma":[316],"(FL),":[317],"Mantle":[319],"Cell":[320,347],"(MCL).":[322],"Also":[323,480],"selected":[324],"involved":[330],"known":[332],"dysregulated":[333],"pathways,":[334],"therapeutic":[335],"targets,":[336],"mapped":[339],"sites":[341],"gains":[344],"losses.":[346],"Origin:":[349],"Immunostains":[350],"BCL6,":[354],"CD10,":[355],"MUM1,":[356],"FOXP1,":[357],"GCET":[358],"LMO2.":[360],"immunostains":[362],"blindly":[364],"scored":[365],"different":[368],"pathologists.":[369],"For":[370],"study,":[372],"GCB":[373],"vs":[374],"ABC":[375],"determination":[376],"made":[378],"Hans":[381],"algorithm":[382],"(CD10,":[383],"BCL6":[384],"MUM1":[386],"expression).":[387],"Statistics:":[388],"Kaplan-Meier":[389],"(KM)":[390],"analysis":[392,422,477,492,534,562],"R":[396],"(version":[397],"3.2.1).":[398],"Results:":[399],"Data":[400],"initial":[403],"subset":[404],"49":[406],"comprehensive":[409],"molecular,":[410],"information":[414],"presented":[416],"(and":[417],"~100":[420],"case":[421],"progress).":[425],"Average":[426],"age":[427],"diagnosis":[434],"63,":[436],"23":[438],"males":[439],"26":[441],"females.":[442],"By":[443,464],"univariate":[444,491,559],"analysis,":[445],"not":[449],"significantly":[450,485,497],"associated":[451,471,486,498],"regimen":[461],"(KM":[462],"p=0.678).":[463],"contrast,":[465],"CNVs":[469,520],"Kaplan":[475],"Meier":[476],"(Table":[478,493],"1).":[479,494],"four,":[481],"poor":[488,523],"Table":[495],"1.Markers":[496],"DLBCL.":[506],"Ab28":[507],"predicted":[508,521],"survival,":[511,578],"whereas":[512],"other":[517],"survival.Gene":[524],"/":[525],"CRp":[526],"(KM)Ab29":[528],"(D1p13.1)0.00787PIK3C2G0.00126PIM10.00499CD79B0.00567DTX10.0102Ab3(A1q21.1-q25.1(3))0.0193Ab28":[529],"(D1p36.32-p36.31)0.0211":[530],"Conclusions:":[531],"Our":[532],"systematic":[533],"multiple":[538],"mutational":[544],"predictive":[549],"patients,":[554],"analysis.":[560],"Multivariate":[561],"cases":[567],"will":[568],"reveal":[569],"whether":[570],"these":[571],"can":[574],"patient":[577],"compared":[579],"(such":[583],"IHC).":[587],"Disclosures":[588],"Friedman:":[589],"Cancer":[590],"Genetics":[591,615],"Inc.,:":[592,616],"Employment,":[593,599,605,611,617],"Equity":[594,600,606,612,618],"Ownership.":[595,601,607,613,619],"Guttapalli:Cancer":[596],"Genetics,":[597,603,609],"Inc.:":[598,604,610],"Thodima:Cancer":[602],"Kamalakaran:Cancer":[608],"Houldsworth:Cancer":[614]},"counts_by_year":[],"updated_date":"2026-09-26T08:19:03.415552","created_date":"2016-07-22T00:00:00"}